Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue |
|---|
| EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
GE GEHC GE HealthCare Technologies Inc. FY ended Jan 28, 2026 | $71.73 | $32.63B | $46.54B | $20.63B | $3.80B | $2.08B | 15.76x | 1.58x | 12.25x |
HO HOLX HOLOGIC INC FY ended Jan 16, 2026 | — | — | — | $4.10B | $926.60M | $565.70M | — | — | — |
BS BSX BOSTON SCIENTIFIC CORP FY ended Jan 30, 2026 | $46.84 | $67.88B | $79.12B | $20.07B | $5.10B | $2.89B | 24.14x | 3.38x | 14.60x |
IS ISRG INTUITIVE SURGICAL INC FY ended Jan 28, 2026 | $372.60 | $131.63B | $126.91B | $10.06B | $3.90B | $2.86B | 47.34x | 13.08x | 32.51x |
ZB ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $100.91 | $19.25B | $23.27B | $8.23B | $1.92B | $705.10M | 28.43x | 2.34x | 12.09x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 17.52x | 4/5 | $7.70B | $7.99 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 5.10x | 4/5 | $90.87B | $94.36 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 28.92x | 4/5 | $25.94B | $26.94 | Included in the active peer mix. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
GE GEHC GE HealthCare Technologies Inc. FY ended Jan 28, 2026 | $71.73 | $32.63B | $46.54B | $20.63B | $3.80B | $2.08B | 15.76x | 1.58x | 12.25x |
HO HOLX HOLOGIC INC FY ended Jan 16, 2026 | — | — | — | $4.10B | $926.60M | $565.70M | — | — | — |
BS BSX BOSTON SCIENTIFIC CORP FY ended Jan 30, 2026 | $46.84 | $67.88B | $79.12B | $20.07B | $5.10B | $2.89B | 24.14x | 3.38x | 14.60x |
IS ISRG INTUITIVE SURGICAL INC FY ended Jan 28, 2026 | $372.60 | $131.63B | $126.91B | $10.06B | $3.90B | $2.86B | 47.34x | 13.08x | 32.51x |
ZB ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $100.91 | $19.25B | $23.27B | $8.23B | $1.92B | $705.10M | 28.43x | 2.34x | 12.09x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 17.52x | 4/5 | $7.70B | $7.99 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 5.10x | 4/5 | $90.87B | $94.36 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 28.92x | 4/5 | $25.94B | $26.94 | Included in the active peer mix. |